Platinum completes $2.1 bln LifeScan buy

Platinum Equity said Oct. 2 its $2.1 billion buy of LifeScan from Johnson & Johnson has closed. LifeScan provides blood glucose monitoring products.

2 October 2018•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles